NOVEL HORMONE COMPOSITION

摘要

The invention relates to the field of therapeutic chemistry, more specifically to hormonal pharmaceutical techniques, especially to novel hormonal pharmaceutical compositions which are formed as a result of an estro-gestagenic association consisting of an estrogen compound and a gestagenic compound, associated with or mixed with one or several non-toxic excipients which are inert and pharmaceutically acceptable and which can be administered orally. The invention also relates to the use of an estro-gestagenic mixture wherein the estrogenic component and the gestagenic component are administered in a combined manner. Combined association can be prescribed in a continuous or intermittent manner with a view to providing a composition which can be used to treat estrogenic deficiency, and prevent osteoporosis and cardiovascular diseases in menopaused women. The invention further relates to a method for the production of said estro-gestagenic compositions.